Interactions of clinical relevance associated with concurrent administration of prescription drug and food or medicinal plants: a systematic review protocol

被引:9
|
作者
Orellana-Paucar, Adriana [1 ]
Vintimilla-Rojas, Daniela [1 ]
机构
[1] Univ Cuenca, Carrera Nutr & Dietet, Fac Ciencias Med, Cuenca, Ecuador
关键词
Concurrent administration; Pharmacological interaction; Food-drug interaction; herb-drug interaction; Safety; Human; HERBAL SUPPLEMENTS; DIETARY; IMPACT; MECHANISMS;
D O I
10.1186/s13643-019-1259-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background An inadequate combination of prescription drugs with food or medicinal plants could cause adverse effects in patients or produce negative therapeutic results. Therefore, this generic systematic review protocol aims to identify and synthesize the literature on clinical characteristics and safety issues of these types of pharmacological interactions occurring in children, adolescents, adults, pregnant/lactating women, and older adults. Methods/design This generic protocol follows the stated guidelines from the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) statement. A literature search will be performed in PubMed, Scopus, and Virtual Health Library (VHL) electronic databases from 1960 till present for studies reporting clinical characteristics and safety issues associated with pharmacological interactions occurring between prescription drugs and food or medicinal plants in participants from birth-age to >= 65-year-old, including pregnant/lactating women. Lateral searching will be carried out in PubMed via related citation. Two reviewers will carry out an independent evaluation of eligible studies as well as the corresponding data extraction of the selected ones. Subsequently, the methodological quality evaluation of the selected articles will be completed using the corresponding Joanna Briggs Institute Checklists. Moreover, the quality of evidence will be graded according to the criteria of the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) Working Group. Quantitative research in humans comprising clinical trials and clinical, comparative and, observational studies will be included. The main outcomes of this protocol involve reported potential food-drug and herb-drug interactions, associated safety issues, and adverse reactions along with the generic name of the prescribed drug and the scientific name of the food and medicinal plants involved in these types of pharmacological interactions. Finally, findings extracted from the selected studies will be summarized in a narrative synthesis. Discussion This generic systematic review protocol seeks to synthesize and critically evaluate current knowledge besides to identify any comprehension gaps in the concurrent administration of prescription drugs with food and herbs. By achieving a better understanding of this topic, this information will allow healthcare professionals to develop useful strategies to recognize, manage, and prevent these types of pharmacological interactions at different age stages, including pregnant/lactating women. Systematic review registration PROSPERO CRD42018117308
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Factors Associated with the Acceptability of Mass Drug Administration for Filariasis: A Systematic Review
    Halim, Ahmad Farid Nazmi Abdul
    Ahmad, Dzulfitree
    Yn, Jane Ling Miaw
    Masdor, Noor Azreen
    Ramly, Nurfatehar
    Othman, Rahayu
    Kandayah, Thinakaran
    Hassan, Mohd Rohaizat
    Dapari, Rahmat
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (19)
  • [22] Clinical Evidence Supporting US Food and Drug Administration Approval of Otolaryngologic Prescription Drug Indications, 2005-2014
    Rathi, Vinay K.
    Wang, Bo
    Ross, Joseph S.
    Downing, Nicholas S.
    Kesselheim, Aaron S.
    Gray, Stacey T.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2017, 156 (04) : 683 - 692
  • [23] Adverse outcomes associated with opioid prescription for acute low back pain: a systematic review protocol
    Natalia Mouravska
    Laura Zielinski
    Meha Bhatt
    Nitika Sanger
    Monica Bawor
    Brittany Dennis
    Laura Banfield
    James MacKillop
    James Paul
    Andrew Worster
    Philip Laplante
    Lehana Thabane
    Zainab Samaan
    Systematic Reviews, 6
  • [24] Adverse outcomes associated with opioid prescription for acute low back pain: a systematic review protocol
    Mouravska, Natalia
    Zielinski, Laura
    Bhatt, Meha
    Sanger, Nitika
    Bawor, Monica
    Dennis, Brittany
    Banfield, Laura
    MacKillop, James
    Paul, James
    Worster, Andrew
    Laplante, Philip
    Thabane, Lehana
    Samaan, Zainab
    SYSTEMATIC REVIEWS, 2017, 6 : 163
  • [25] SILDENAFIL AND FUROSEMIDE ASSOCIATED OTOTOXICITY: CONSIDERATION OF DRUG-DRUG INTERACTIONS, SYNERGY, AND BROADER CLINICAL RELEVANCE
    Skeith, Leslie
    Yamashita, Cory
    Mehta, Sanjay
    Farquhar, Donald
    Kim, Richard B.
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2013, 20 (02): : E128 - E131
  • [26] Clinical Relevance of Drug Interactions in People Living with Human Immunodeficiency Virus on Antiretroviral Therapy-Update 2022: Systematic Review
    Amariles, Pedro
    Rivera-Cadavid, Monica
    Ceballos, Mauricio
    PHARMACEUTICS, 2023, 15 (10)
  • [27] Risk Assessment of Genetically Modified Food and Neoliberalism: An Argument for Democratizing the Regulatory Review Protocol of the Food and Drug Administration
    Meghani, Zahra
    JOURNAL OF AGRICULTURAL & ENVIRONMENTAL ETHICS, 2014, 27 (06): : 967 - 989
  • [28] Risk Assessment of Genetically Modified Food and Neoliberalism: An Argument for Democratizing the Regulatory Review Protocol of the Food and Drug Administration
    Zahra Meghani
    Journal of Agricultural and Environmental Ethics, 2014, 27 : 967 - 989
  • [29] Systematic Review of Medicinal Plants Used for Treatment of Diabetes in Human Clinical Trials: An ASEAN Perspective
    Salleh, Nazurah Hamizah
    Zulkipli, Ihsan Nazurah
    Mohd Yasin, Hartini
    Ja'afar, Fairuzeta
    Ahmad, Norhayati
    Wan Ahmad, Wan Amir Nizam
    Ahmad, Siti Rohaiza
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [30] A Systematic Review Of The Food And Drug Administration's 'Exception From Informed Consent' Pathway
    Feldman, William B.
    Hey, Spencer Phillips
    Kesselheim, Aaron S.
    HEALTH AFFAIRS, 2018, 37 (10) : 1605 - 1614